T. Rowe Price Associates
ZURA icon

T. Rowe Price Associates’s Zura Bio ZURA Stock Holding History

T. Rowe Price Associates’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,830
Closed -$27K – 3161
2025
Q1 		$27K Hold
20,830
– – ﹤0.01% 2988
2024
Q4 		$53K Buy
20,830
+5,506
+36% +$19.6K ﹤0.01% 2936
2024
Q3 		$63K Buy
+15,324
New +$57.2K ﹤0.01% 2901

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

T. Rowe Price Associates's ZURA Position: Q2 2025 in Review

T. Rowe Price Associates sold out of Zura Bio (ZURA) in Q2 2025, closing a stake of 20,830 shares — an estimated $27K sold.

T. Rowe Price Associates first reported a position in ZURA in Q3 2024 and held it in 3 quarters. The position peaked at $63K in Q3 2024. 65 funds tracked by Wall St. Rank hold ZURA as of Q2 2025.

  • T. Rowe Price Associates reported no remaining Zura Bio position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 20,830 Zura Bio shares in Q2 2025, an estimated $27K.
  • T. Rowe Price Associates first reported a position in Zura Bio in Q3 2024 and held it in 3 quarters.
  • T. Rowe Price Associates's Zura Bio position peaked at $63K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held Zura Bio as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.